Cannabidiol Modulates the Motor Profile and NMDA Receptor-related Alterations Induced by Ketamine
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 454, 105-115
Abstract
No abstract availableKeywords
Funding Information
- General Secretariat for Research and Innovation
This publication has 73 references indexed in Scilit:
- Cannabidiol in Humans—The Quest for Therapeutic TargetsPharmaceuticals, 2012
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophreniaTranslational Psychiatry, 2012
- Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophreniaNeuroscience, 2011
- Effect of cannabidiol in a MK-801-rodent model of aspects of SchizophreniaBehavioural Brain Research, 2011
- Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathwayNeuroscience, 2011
- Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymesBritish Journal of Pharmacology, 2010
- NMDA Receptor Hypofunction Phase Couples Independent γ-Oscillations in the Rat Visual CortexNeuropsychopharmacology, 2010
- Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedureLife Sciences, 2009
- Tyrosine Phosphorylation of the N-Methyl-D-Aspartate Receptor 2B Subunit in Spinal Cord Contributes to Remifentanil-Induced Postoperative Hyperalgesia: the Preventive Effect of KetamineMolecular Pain, 2009
- The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitementMolecular Psychiatry, 2008